source
- Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipelineCentered around a glaucoma therapy in mid-stage testing, the deal is Bayer’s first drug company acquisition in several years and potentially its largest since it purchased AskBio in 2020.BioPharma Dive · 2mo ago↗ source
- Transformational Utah Investment in Artificial Intelligence and Computing to Advance Health and DiscoveryThe State of Utah has made a visionary investment in AI and advanced computing infrastructure to advance research.onclive · 2mo ago↗ source
- STAT+: Color Health moving deeper into cancer services, complete with virtual ‘tumor boards’Color Health, which coordinates cancer screening, is moving into a gap it observed — obtaining and coordinating actual cancer care.